Second Affiliated Hospital of Harbin Medical University

Running trials

• Not yet recruiting

  Clinical Trial of SEEG for Drug-resistant Epilepsy

  NCT07923058· Beijing Pins Medical Co., Ltd· Source

• Not yet recruiting

  Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response

  NCT07797231· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Recruiting

  Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis

  NCT07796516· Phase 2· Peking University People's Hospital· Source

• Recruiting

  Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration

  NCT07776522· Phase 2· West China Hospital· Source

• Recruiting

  Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)

  NCT07567625· Harbin Medical University· Source

• Recruiting

  Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities

  NCT07781124· Vantive Health LLC· Source

• Recruiting

  SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

  NCT07710248· Phase 2· Hangzhou Sumgen Biotech Co., Ltd.· Source

• Not yet recruiting

  Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma

  NCT07569757· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Recruiting

  Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation

  NCT07444372· Beijing Anzhen Hospital· Source

• Recruiting

  SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)

  NCT07316270· Beijing Anzhen Hospital· Source

• Not yet recruiting

  Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis

  NCT07566065· Chinese Academy of Medical Sciences, Fuwai Hospital· Source

• Enrolling by invitation

  A Coronary Computed Tomography Angiography-guided Intervention for High Risk Cardiovascular Disease Population in Rural China

  NCT07416344· Harbin Medical University· Source

• Not yet recruiting

  A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis

  NCT07432854· Phase 2/3· Dermavon Holdings Limited· Source

• Active, not recruiting

  Time-Restricted Eating for Weight-Loss Maintenance

  NCT07163455· Harbin Medical University· Source

• Recruiting

  Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

  NCT07317934· Phase 3· Innostellar Biotherapeutics Co.,Ltd· Source

• Recruiting

  A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease

  NCT07187440· Takeda· Source

• Recruiting

  Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation

  NCT06871228· Beijing Anzhen Hospital· Source

• Recruiting

  Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy

  NCT07030881· First Affiliated Hospital of Ningbo University· Source

• Recruiting

  A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy

  NCT07010263· Phase 3· Akeso· Source

• Not yet recruiting

  Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer

  NCT07007286· Peking University First Hospital· Source

• Recruiting

  Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial

  NCT06883864· Beijing Anzhen Hospital· Source

• Recruiting

  Remote Anxiety Management for ICS-resistant Asthma Study

  NCT06732141· First Affiliated Hospital of Ningbo University· Source

• Recruiting

  A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer

  NCT06568094· Phase 1/2· Jiangsu HengRui Medicine Co., Ltd.· Source

• Recruiting

  PulseSelect™ PFA Global Registry

  NCT06393920· Medtronic Cardiac Ablation Solutions· Source

• Recruiting

  A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

  NCT06413654· Phase 2/3· Shanghai Jiaolian Drug Research and Development Co., Ltd· Source

• Recruiting

  Single-cell Multi-omics Analyses of OCT-diagnosed Plaque Subtypes in Coronary Artery Disease (MOOP-CAD)

  NCT06489119· Harbin Medical University· Source

• Active, not recruiting

  A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)

  NCT05562947· Phase 3· Hoffmann-La Roche· Source

• Not yet recruiting

  Henagliflozin's Impact on Prediabetes Remission

  NCT06448130· Phase 4· Shandong Provincial Hospital· Source

• Recruiting

  Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

  NCT06365502· Harbin Medical University· Source

• Recruiting

  D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

  NCT06300177· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Recruiting

  Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)

  NCT06157502· Phase 3· Beijing Tiantan Hospital· Source

• Recruiting

  China HeadAche DIsorders RegiStry

  NCT05334927· Beijing Tiantan Hospital· Source

• Active, not recruiting

  To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer

  NCT05365178· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Active, not recruiting

  A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer

  NCT04854668· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Recruiting

  Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery

  NCT03349762· Xi Shan Wang· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation4 recruiting
• Coronary artery disease4 recruiting
• Asthma2 recruiting
• Hepatitis B2 recruiting
• High blood pressure2 recruiting
• Lung cancer2 recruiting
• Macular degeneration2 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• COPD1 recruiting
• Epilepsy1 recruiting
• Fabry disease1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Liver and biliary tract cancer1 recruiting
• Migraine1 recruiting
• Multiple myeloma1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Obstructive sleep apnoea1 recruiting
• Prostate cancer1 recruiting
• Psoriasis1 recruiting
• Rheumatoid arthritis1 recruiting
• Stroke1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects

  NCT07357831· Phase 3· Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.· Source

• Terminated

  A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

  NCT07100938· Phase 2· BeiGene· Source

• Completed

  HPP737 in Adult Patients With Plaque Psoriasis

  NCT07712731· Phase 3· Newsoara Biopharma Co., Ltd.· Source

• Completed

  The Impact of Comprehensive Post Hospital Management Based on DHI on Cardiac Function in Patients With HF

  NCT06947148· Harbin Medical University· Source

• Completed

  Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study

  NCT06648772· Phase 3· Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.· Source

• Completed

  To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

  NCT06552520· Phase 3· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Source

• Completed

  An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

  NCT06421740· AbbVie· Source

• Completed

  Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06477237· Phase 3· Huabo Biopharm Co., Ltd.· Source

• Completed

  Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)

  NCT06037889· Phase 3· Peking Union Medical College Hospital· Source

• Terminated

  TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

  NCT06106841· Phase 1/2· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Source

• Completed

  Robotic Natural Orifice Specimen Extraction Surgery Versus Robotic Transabdominal Specimen Extraction Surgery for Early-Stage Rectal Cancer

  NCT06405308· Taiyuan Li· Source

• Completed

  Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

  NCT06018181· Dongzhimen Hospital, Beijing· Source

• Completed

  HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

  NCT07712705· Phase 3· Newsoara Biopharma Co., Ltd.· Source

• Completed

  Study of Telitacicept in Generalized Myasthenia Gravis

  NCT05737160· Phase 3· RemeGen Co., Ltd.· Source

• Completed

  A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

  NCT05583838· Phase 4· Institute of Hematology & Blood Diseases Hospital, China· Source

• Completed

  Chinese Osteoporotic Fracture Registration Network Platform

  NCT05339425· Peking Union Medical College Hospital· Source

• Completed

  A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)

  NCT05083923· Phase 3· Biogen· Source

• Completed

  Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)

  NCT04937803· Harbin Medical University· Source

• Completed

  Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

  NCT04624854· Phase 4· Harbin Medical University· Source

• Completed

  PROMUS PREMIER™ China Post-Approval Study

  NCT03273023· Boston Scientific Corporation· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Thyroid cancer13 works · 0 trials
• Myasthenia gravis11 works · 1 trial
• Idiopathic pulmonary fibrosis11 works · 0 trials